NCT07343960 2026-02-24A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic ImpairmentAstraZenecaPhase 1 Recruiting20 enrolled
NCT05039801 2025-10-14IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsM.D. Anderson Cancer CenterPhase 1 Recruiting54 enrolled